Clinical trial

SWitching to Abilify Trial (SWAT)

NCT00304616

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-10-01

PhasePHASE4

Study timeline

Study start (unknown)2004-10-01Date precision: month

Registry last updated2009-12-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Aripiprazole, Solian, Olanzapine, Seroquel, RisperidoneDRUG

Sponsors & collaborators

Korea Otsuka Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00304616 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.